Biomind Labs Inc.
BMND
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -5.95% | -18.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.95% | -19.70% | |||
| Operating Income | 5.95% | 19.70% | |||
| Income Before Tax | 11.76% | -74.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.76% | -74.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.76% | -74.40% | |||
| EBIT | 5.95% | 19.70% | |||
| EBITDA | 5.95% | 18.14% | |||
| EPS Basic | 13.33% | -66.67% | |||
| Normalized Basic EPS | 11.11% | 18.18% | |||
| EPS Diluted | 13.33% | -66.67% | |||
| Normalized Diluted EPS | 11.11% | 18.18% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||